Sensitive

Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)

LOC100505718 · rs16935279

What each result means

C/C Published research associates this genotype (two copies of the reported risk allele) with a higher likelihood of Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio) compared to the general population.
C/T Published research associates this genotype (one copy of the reported risk allele) with an intermediate association with Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio).
T/T Published research associates this genotype with typical/baseline likelihood of Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio) — no copies of the reported risk allele.
Source

Questions about rs16935279

What is rs16935279?

rs16935279 is a single position in the genome, in or near the LOC100505718 gene. Published research associates it with pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio). A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.

Does having rs16935279 mean I will get this?

No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.

Where does the information about rs16935279 come from?

GWAS Catalog, J Psychopharmacol 2015, PMID:25944848. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.

← See all variants